XML 53 R32.htm IDEA: XBRL DOCUMENT v3.25.3
Segment and Enterprise Reporting
 9 Months Ended
Sep. 27, 2025
Segment Reporting [Abstract]  
Segment and Enterprise Reporting
25. Segment and Enterprise Reporting
The Company’s reportable segments are determined based upon the Company’s organizational structure and the way in which the Company’s Chief Operating Decision Maker (CODM), the Company’s CEO, makes operating decisions, assesses financial performance, and allocates resources. As of September 27, 2025, the Company operates under one reportable segment, the healthcare business. Earlier this year, the non-healthcare consumer audio business was classified as held-for-sale, and as a result was excluded from the segment and enterprise reporting herein for all periods presented. On September 23, 2025, the Company completed the sale of its non-healthcare business.
The Company’s CODM uses segment gross profit, as presented in the Company’ CODM reports, as the primary measure of segment profitability. The significant segment expenses help the Company to better understand operating results. Segment information presented herein reflects the impact of these changes for all periods presented.
Selected information for the healthcare segment is presented below for each of the three and nine months ended September 27, 2025 and September 28, 2024:
Three Months Ended
Nine Months Ended
(in millions)September 27,
2025		September 28,
2024		September 27,
2025		September 28,
2024
Revenues:
Healthcare$371.2 $343.3 $1,112.5 $1,026.8 
Other(1)
0.3 — 1.9 — 
Total revenues$371.5 $343.3 $1,114.4 $1,026.8 
Cost of goods:
Healthcare
$140.4 $127.3 $414.9 $384.5 
Other(1)
0.5 3.9 1.6 16.3 
Total costs of goods sold$140.9 $131.2 $416.5 $400.8 
Gross profit:
Segment gross profit$230.8 $215.9 $697.7 $642.2 
Acquired asset amortization(1)(2)
(0.3)(0.5)(0.9)(1.5)
Business transition and related costs(1)(3)
0.1 (5.2)1.2 (12.3)
Acquisitions, integrations, divestitures, and
related costs(1)(4)
— — — (0.1)
Other(1)
— 1.9 (0.1)(2.3)
Total gross profit$230.6 $212.1 $697.9 $626.0 
____________________________
(1)     Management excludes certain revenues and expenses from segment gross profit. Management considers these excluded amounts to be non-recurring or non-operational and as such, are excluded from segment gross profit as this enables management to better understand operational results.
(2)     Acquired asset amortization is a non-GAAP financial measure. These transactions represent amortization expense in connection with business or assets acquisitions associated with acquired intangible assets including, but not limited to customer relationships, intellectual property, trade names and non-competition agreements.
(3)     Business transition and related costs is a non-GAAP financial measure. These transactions represent gains, losses, and other related costs associated with business transition plans. These items may include but are not limited to severance, relocation, consulting, leasehold exit costs, asset impairment, and other related costs to rationalize our operational footprint and optimize business results.
(4)     Acquisitions, integrations, divestitures, and related costs are a non-GAAP financial measure. These transactions represent gains, losses, and other related costs associated with acquisitions, integrations, investments, divestitures, assets impairments, and in-process research and development.
For the three months ended September 27, 2025, and September 28, 2024, total depreciation and amortization expense for the healthcare segment was $8.1 million and $10.2 million, respectively. For the nine months ended September 27, 2025, and September 28, 2024, total depreciation and amortization expense for the healthcare segment was $25.2 million and $30.8 million, respectively.